Precigen Inc PGEN:NASDAQ

Last Price$1.25Cboe Real-Time Last Sale as of 3:39PM ET 5/20/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.005(0.40%)
Bid (Size)$1.24 (800)
Ask (Size)$1.25 (1,697)
Day Low / High$1.22 - 1.28
Volume760.5 K
  • Latest Stories
  • Commentary and Analysis
-- Earnings Flash (PGEN) PRECIGEN Reports Q1 Revenue $32M, vs. Street Est of $23.3M
4:39PM ET 5/09/2022 MT Newswires

...

Precigen's Acute Myeloid Leukemia Treatment Candidate Gets FDA Fast Track Designation
11:04AM ET 4/04/2022 MT Newswires

Precigen (PGEN) said Monday the US Food and Drug Administration granted fast track designation to its PRGN-3006 UltraCAR-T treatment for relapsed or...

-- Earnings Flash (PGEN) PRECIGEN Reports Q4 Revenue $24.2M, vs. Street Est of $22.2M
8:02AM ET 3/01/2022 MT Newswires

...

Insider Buy: Precigen
5:06PM ET 11/30/2021 MT Newswires

Harry Thomasian Jr., Chief Financial Officer, on November 26, 2021, executed a purchase for 26,500 shares in Precigen (PGEN) for $100,831. Following the...

Insider Buy: Precigen
6:00AM ET 11/24/2021 MT Newswires

Randal J Kirk, 10% Owner, Director, on November 19, 2021, executed a purchase for 1,000,000 shares in Precigen (PGEN) for $3,634,787. Following the Form 4...

Precigen Gets FDA Nod to Begin Early-Stage PRGN-3007 Trial in Hematological, Solid Tumors
1:54PM ET 10/26/2021 MT Newswires

Precigen (PGEN) said Tuesday that the US Food and Drug Administration has approved its investigational new drug application to initiate the phase 1/1b test...

Precigen Appoints CFO
10:16AM ET 10/12/2021 MT Newswires

Precigen (PGEN) said Tuesday that Harry Thomasian Jr. was named as its new CFO effective Oct. 18. Thomasian served most recently as senior client services...

Precigen Releases Additional Type 1 Diabetes Treatment Trial Data, Sees Potential as 'Standalone Therapy'
9:44AM ET 10/01/2021 MT Newswires

Precigen (PGEN) said Friday newly released additional interim data from an ongoing clinical trial of its type 1 diabetes treatment indicates its potential...

Insider Trends: 90-Day Insider Selling Trend Prolonged at Precigen
6:03PM ET 8/17/2021 MT Newswires

Ares Trading SA, 10% Owner, on Aug 13, 2021, sold 58,344 shares in Precigen (PGEN) for $361,080. Ares Trading, following the transactions outlined in the...

Insider Trends: Selling By Insiders Lingers at Precigen
6:02PM ET 8/13/2021 MT Newswires

On Aug 11, 2021, 10% Owner, Ares Trading SA, executed a sale of 308,484 shares in Precigen (PGEN) for $1,884,067. Ares Trading, following the transactions...